Overview

A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer